glp 1 canada weight loss GLP-1s for Loss: What You Need to Know Beyond Weight Loss: ED Implications

An observational cohort study based in four Nordic countries evaluated periconception exposure to oral hypoglycaemic agents (OHAs) and glucose-like peptide-1 receptor agonists (GLP-1 RAs)

(35(9)):1256.e1-1256.e2 doi:10.1016/j.cjca.2019.05.014

If you're like most men on testosterone replacement

Vukojevic, J., et al., Pentadecapeptide BPC 157 and the central nervous system

Best Human Growth Hormone-Releasing Peptide

Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)